Archive for the ‘Uncategorized’ Category

Sign Up Today: HHS Virtual Session on TBDs & Diagnosis

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/33132197?

Sign Up Today! HHS Virtual Session on Tick-Borne Diseases and Diagnosis

Carl Tuttle
Hudson, NH, United States
Dec 27, 2024

I received an invitation from the Office of Infectious Disease and HIV/AIDS Policy (OIDP) to submit questions in relation to their “National Community Engagement Initiative” which came out of the Tick-Borne Disease Working Group established by Congress in 2016 as part of the 21st Century Cures Act.  This so-called working group turned out to be a total farce as those in charge refused to acknowledge chronic Lyme disease; the illusion of a working group.

My questions follow: (How about everyone reading this demand a response?)

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “James.Berger@hhs.gov” <James.Berger@hhs.gov>, “tickbornedisease@hhs.gov” <tickbornedisease@hhs.gov>
Cc: “tbdengagement@roseliassociates.com” <tbdengagement@roseliassociates.com>, “kaye.hayes@hhs.gov” <kaye.hayes@hhs.gov>, “ross_boyce@med.unc.edu” <ross_boyce@med.unc.edu>, “ASH@hhs.gov” <ASH@hhs.gov>, “OIDP-HAI@hhs.gov” <OIDP-HAI@hhs.gov>, “mwcurtis@bcm.edu” <mwcurtis@bcm.edu>, “job.lopez@bcm.edu” <job.lopez@bcm.edu>, “michael.a.boatwright2.mil@health.mil” <michael.a.boatwright2.mil@health.mil>, “tlalani@idcrp.org” <tlalani@idcrp.org>, “Schotthoefer.Anna@MarshfieldResearch.org” <Schotthoefer.Anna@MarshfieldResearch.org>, “Linz.Alexandra@MarshfieldResearch.org” <Linz.Alexandra@MarshfieldResearch.org>, “lashyra_nolen@hms.harvard.edu” <lashyra_nolen@hms.harvard.edu>, “bennett.nemser@steveandalex.org” <bennett.nemser@steveandalex.org>

Date: 12/26/2024 9:47 AM EST
Subject: Re: Sign Up Today! HHS Virtual Session on Tick-Borne Diseases and Diagnosis

Tick-Borne Disease and Associated Illnesses Virtual Community Engagement Session
https://www.hhs.gov/oidp/initiatives/tick-borne-diseases-associated-illnesses-national-community-engagement-initiative/index.html
Thursday, January 28th, 1:00 pm – 4:15 PM Eastern

“If you would like to submit a question for one of the speakers, please send it by Jan 17th at 11:59 PM to tickbornedisease@hhs.gov. Questions will be compiled prior to the meeting and presented to the speakers during the Q&A sessions.” 

ATTN: James Berger, MS, MT(ASCP), SBB
Office of Infectious Disease and HIV/AIDS Policy (OIDP)

In reference to Lyme disease; There are literally hundreds and hundreds of publications identifying persistent infection after antibiotic treatment dating all the way back to 1977.

Here is just one example from 1995: 

European Neurology 1995
Seronegative Chronic Relapsing Neuroborreliosis
https://www.karger.com/Article/Abstract/117104
Lawrence C., Lipton R.B., Lowy F.D., Coyle P.K.d

Abstract 
We report an unusual patient with evidence of Borrelia burgdorferi infection who experienced repeated neurologic relapses despite aggressive antibiotic therapy. Each course of therapy was associated with a Jarisch-Herxheimer-like reaction. Although the patient never had detectable free antibodies to B. burgdorferi in serum or spinal fluid, the CSF was positive on multiple occasions for complexed anti-B. burgdorferi antibodies, B. burgdorferi nucleic acids and free antigen.

Questions:  
What is the motivation driving the deliberate suppression of this evidence identifying Borrelia burgdorferi as an antibiotic resistant/tolerant superbug? Does a chronic relapsing seronegative disease fit the vaccine model?

Carl Tuttle
Independent Researcher
Hudson, NH

“The Quiet Epidemic” Showing at the U.S. Capital Nov. 20, 2024

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/

The Quiet Epidemic Film Presentation at the U.S. Capitol November 20th

Carl Tuttle
Hudson, NH, United States
Oct 29, 2024

The Quiet Epidemic Film Presentation at the U.S. Capitol

Please join us on Capitol Hill for a special presentation of the award-winning documentary The Quiet Epidemic

Hosted by Senator Richard Blumenthal, with a special appearance by Chris Meloni, Actor & Global Lyme Alliance Celebrity Ambassador

Since the earliest days of production, the team and supporters behind The Quiet Epidemic hoped the film might one day screen on Capitol Hill, and that moment has arrived.

Please join us for a free and open to the public presentation of The Quiet Epidemic on Wednesday, November 20th, from 5:30 PM to 9:00 PM, at the U.S. Capitol. The film will be preceded by a reception and followed by a discussion and Q&A with the film’s subjects, experts and actor Chris Meloni.

While the event is free to attend, RSVPs via Eventbrite are required for entry. You’ll find a PDF invitation attached to this email which includes the RSVP link—please circulate this widely, as our team is prohibited from promoting the event on social media. Details regarding the exact venue location within the Capitol will be sent to all registrants via Eventbrite approximately one week prior to November 20th.

The Quiet Epidemic team would like to thank our generous sponsors who have made our Capitol Hill events possible: LymeLight Foundation, Global Lyme Alliance, Sarena Snider, Project Lyme, NatCapLyme and lymeLNK. Among our sponsors are The Quiet Epidemic Executive Producers Phyllis & Scott Bedford—founders of LymeLight Foundation—and Sarena Sarena, each of whom generously supported the creation of the film itself, the film’s festival tour and release, and our team since the very beginning.

Please share the Eventbrite link and the attached PDF with anyone in your network who may wish to attend this event—especally those in the Washington D.C. area. We also encourage you to invite your representatives and include a brief statement about the impact Lyme has had on your life, and the prevalence in their state.

PDF invitation

https://www.dropbox.com/scl/fi/rp1qqnln1w6ztk6yimecq/11.20.24_The-Quiet-Epidemic-on-Capitol-Hill.pdf?rlkey=ecmsm63kwn8w27pymi1x8dlqk&dl=0

This is a culminating moment for The Quiet Epidemic film and impact campaign, nine years in the making. Thank you for being a part of this journey and for making it possible in so many ways! We hope to see you in D.C.

With gratitude,
The Quiet Epidemic Team

Watch The Quiet Epidemic trailer:
https://www.youtube.com/watch?v=I4C71N290co

23andMe Reportedly Faces Bankruptcy – What Will Happen to Everyone’s DNA Samples?

https://activistpost.com/2024/10/23andme-reportedly-faces-bankruptcy-what-will-happen-to-everyones-dna-samples.

23andMe Reportedly Faces Bankruptcy — What Will Happen to Everyone’s DNA Samples?

By Megan PrictorThe University of Melbourne

Since it was founded nearly two decades ago, 23andMe has grown into one of the largest biotechnology companies in the world. Millions of people have used its simple genetic testing service, which involves ordering a saliva test, spitting into a tube, and sending it back to the company for a detailed DNA analysis.

But now the company is on the brink of bankruptcy. This has raised concerns about what will happen to the troves of genetic data it has in its possession.

The company’s chief executive, Anne Wojcicki, has said she is committed to customer privacy and will “maintain our current privacy policy”.

But what can customers of 23andMe themselves do to make sure their highly personal genetic data is protected? And should we be concerned about other companies that also collect our DNA?

What happened to 23andMe?

23andMe has had a rapid downfall after the 2021 high of its public listing.

Its value has dropped more than 97%. In 2023 it suffered a major data breach affecting almost seven million users, and settled a class action lawsuit for US$30 million.

Last month its seven independent directors resigned amid news the original founder is planning to take the company private once more. The company has never made a profit and is reportedly on the verge of bankruptcy.

What this might mean for its vast stores of genetic data is unclear.  (See link for article)

______________

**Comment**

Many Lyme/MSIDS patients have had this genetic testing done, often to determine if they have a problem detoxing due to genetics.

The article advises:

The simplest thing is to delete your account, which opts you out of any future research and discards your saliva sample. But if your data has already been de-identified and used in research, it can’t be retrieved. And even if you delete your account, 23andMe says it will keep hold of information including your genetic data, date of birth and sex, to comply with its own legal obligations.

For more:

Biologists Map DNA of 47 Strains of Lyme Disease

https://www.lymedisease.org/map-dna-lyme-disease-bacteria/

Biologists map the DNA of 47 strains of Lyme disease

By City University of New York

August 15, 2024

A team led by CUNY Graduate Center biologists has produced a genetic analysis of Lyme disease bacteria that may pave the way for improved diagnosis, treatment, and prevention of the tick-borne ailment.

Weigang Qiu, a professor of biology at the CUNY Graduate Center and Hunter College, and an international team mapped the complete genetic makeup of 47 strains of Lyme disease-related bacteria from around the world. This created a powerful tool for identifying the bacterial strains that infect patients.

More accurate tests and treatments?

Researchers said this could enable more accurate diagnostic tests and treatments tailored to the bacteria causing each patient’s illness.

“By understanding how these bacteria evolve and exchange genetic material, we’re better equipped to monitor their spread and respond to their ability to cause disease in humans,” said Qiu, the corresponding author of the study.

The study was published in mBio, the flagship journal of the American Society for Microbiology.

Researchers said the genetic information uncovered in the study may help scientists develop more effective vaccines against Lyme disease.

Lyme disease is the most common tick-borne illness in North America and Europe, affecting hundreds of thousands of people a year. The disease arises from bacteria belonging to the Borrelia burgdorferi sensu lato group, which infect people through the bite of infected ticks. Symptoms can include fever, headache, fatigue, and a characteristic skin rash. If left untreated, the infection can spread to joints, the heart, and the nervous system, causing more severe complications.

Case numbers are increasing steadily, with 476,000 new cases each year in the United States, and may grow faster with climate change, the authors of the study said.

The research team sequenced the complete genomes of Lyme disease bacteria representing all 23 known species in the group. Most hadn’t been sequenced before the effort. The National Institutes of Health-funded project included many bacteria strains most associated with human infections and species not known to cause disease in humans.

Evolutionary history of Lyme bacteria

By comparing these genomes, the researchers reconstructed the evolutionary history of Lyme disease bacteria, tracing the origins back millions of years. They discovered the bacteria likely originated before the breakup of the ancient supercontinent Pangea, explaining the current worldwide distribution.

The study also disclosed how these bacteria exchange genetic material in and between species. This process, known as recombination, allows the bacteria to rapidly evolve and adapt to new environments. The researchers identified specific hot spots in the bacterial genomes where this genetic exchange occurs most frequently, often involving genes that help the bacteria interact with their tick vectors and animal hosts.

To facilitate ongoing research, the team has developed web-based software tools (BorreliaBase.org) that allow scientists to compare Borrelia genomes and identify determinants of human pathogenicity.

Looking ahead, the researchers said they plan to expand their analysis to include more strains of Lyme disease bacteria, especially from understudied regions. They also aim to investigate the functions of genes unique to disease-causing strains, which could uncover new targets for therapeutic interventions.

As Lyme disease expands its geographic range because of climate change, the research provides valuable tools and insights for combating this rising public health threat.

The study is supported by grants from NIH and an award from the Steven and Alexandra Cohen Foundation.

Click here to read the study.

SOURCE:  CUNY Office of Communications and Marketing

________________

**Comment**

Predictably, the study throws in the globalist talking points of vaccines and climate change, despite there being major disagreements within the scientific community on both issues.

While mapping the strains of borrelia should be good news, nothing will come of this but more lucrative vaccines that will maim and kill many people.  No good tests and no effective treatments will be created.

How do I know?

University research has been hijacked.  NIH, HHS, CDC, and FDA are bought out agencies.  We will get nothing helpful from them.  COVID exposed to all with eyes to see and ears to hear that ‘public health’ isn’t about health at all but  is about power and money.

Patients mean absolutely nothing to these players.

______________

For more:

How to Track Progress When Treating Lyme/MSIDS

https://www.lymedisease.org/the-last-5-minutes-remember-progress-comes-in-inches-not-feet/

THE LAST 5 MINUTES: Remember, progress comes in inches, not feet

7/10/24

In a previous blog, THE LAST 5 MINUTES: 8 Concepts and Contemplations in Healing, nurse practitioner Mindy Daigle discusses eight ideas that can help a person heal. In the following post, she zeroes in on item #2 on her list.

By Mindy Daigle, NP

It’s such a long slog that sometimes I really don’t know if I am making any progress.” This is a common statement from my patients as we start out the appointment.

At the beginning of every encounter, I inquire about how they are feeling overall and how they feel about where they are in this process. I ask where is the needle moving: Better? Worse? Plateaued? It’s a sort of quick progress report.

We then move into what I call five broad categories: pain, sleep, mood, gut and energy. They report generally and in detail on each category then delve into all other body systems.

Treatment progress can be slow with chronic Lyme disease and many chronic conditions. Sometimes described as a process of one step forward, two steps back, the next month may be two steps forward with just one step back.

Knowing that advancements are made slowly can set a realistic expectation when estimating recovery time. There are times, especially in the beginning of treatment, when drastic improvements are made very quickly. This can lead to a belief that changes will continue to happen rapidly, when that is usually not the case.

Over time it can become difficult to notice the wins and improvements. It can be challenging to determine when there is treatment failure versus plateau versus slow progress.

Tracking symptoms

Two practical ways to approach this are by symptom-tracking and note-taking in between appointments. We have patients track their changes at every visit. This allows the patient to notice trends and allows me to judge effectiveness of treatments and to guide therapy.

With each appointment, I review symptom tracking sheets from the three most recent visits, along with the World Health Organization Disability Assessment Score and the Horowitz Tick-Borne Disease Questionnaire.

We look together at the more recent trends and when necessary go further back in time.  At certain intervals we review symptom-tracking from one year prior and then back to the initial consultation, judging efficacy of therapies over much longer time periods.

We can take a close-up view or zoom out to see the trends over time more clearly. We discuss  symptoms from the past that have resolved, new ones that appear and sometimes note that new symptoms may be a sign of treatment success rather than failure.

Ways to do this

There are many ways that you can incorporate this into your life, I have seen many examples in my practice. One patient is a full-time data scientist. He uses the power of his personal data to track his progress over time.

Five days a week, he uses spreadsheets to record an exhaustive list of the severity of his symptoms such as pain and fatigue along with objective findings such as vital signs, lab findings and treatment changes. When faced with a challenging time or a period of perceived stagnation, he reviews his tracker, identifies patterns and usually realizes that momentum is present, and takes that as a win. When he is plateaued or regressing, he holds tight to what is working and gives himself grace.

Another patient who is technology-averse keeps a written weekly journal. She gives an overall score for her main categories of symptoms but not an exhaustive list of every symptom. When she is feeling that she is not moving forward, she refers to her notes and asks for input from her family and support system. She is focused on showing herself kindness, celebrating her wins and accepting that there are times without real progress.

Look for small changes

Most of the time, the changes are not dramatic or quick. It can feel like there is no headway being made, left seemingly without hope of improvement. It is in these times that you can identify the small changes and hold on to them as wins. Pain may have decreased from a 6 to a 5 then at the next appointment may be a 4. Take that as a win.

Then there are times progress is not happening or is too slow. It can be tempting during these plateaus or regressions to push forward, past our limitations without regard for consequences. This is akin to having ambition without direction and is not advisable. That’s when we take a deeper look at the overall treatment plan and then retool the protocol. Working together as patient and clinician, we notice the strides taken and the setbacks suffered and continue to plan a way forward.

In the 2023 chronic Lyme-focused documentary,  “I’m Not Crazy, I’m Sick,” they interview Peter, father of Atty, a  young lady with Lyme. In spite of spending hundreds of thousands of dollars on the best possible care for Atty, she remains ill.

There are times when she is feeling better, but not for long. It often seems that no progress has been made. Voicing his frustrations with the ordeal, Peter states “We take steps forward, but it’s a thousand mile walk.” He accurately and succinctly describes the process that he and his family along with millions of others endure as they navigate treatment.

Matters of the heart

In the last five minutes of our appointment, after completing the thorough exam and assessment, my patient and I speak about matters of the heart and how to use this process as fuel for our healing. We heal in this process of slow progress through awareness of our experiences, patience along the way, compassion for ourselves, and persistence in our actions. We continue to do what we know helps, turn away from what harms, and then take the next steps in our healing.

Have you had experience with this concept of progress being made in inches not feet? Tell me about it at mindydaigleNP@gmail.com Thank you to all who have written, I enjoy and benefit from reading your stories and experiences. Also to note, since the first article was published, I have changed the title of this contemplation to better reflect my experience.

See also: THE LAST 5 MINUTES: How “keyhole sunsets” can help you heal

Mindy Tobin Daigle is a Nurse Practitioner at Green Oaks Medical Center, in Palo Alto, California. She collaborates with Dr. Christine Green, a Lyme and Tick-Borne Disease Specialist.

_________________

**Comment**

A very important topic that doesn’t get a lot of attention.

I whole-heartedly agree with keeping track of symptoms.  The easier you make this, the better. Like all else, if it’s too difficult you won’t do it!  I got a ‘month at a glance’ calendar with lines/space to write each day’s symptoms.  Since I had to keep track of two people, this was indispensable for me.  I then typed up an executive summary for each of us.  These were the backbone that guided our treatment.  If you don’t do this or something similar, you are flying blind and your practitioner will only be able to help you so much.  In order to get the best care possible, you must be an active part of this process.

For more: